NIHON TRIM.,CO.LTD.【JP:6788】Stock Price

Japan Trim has two main business segments: Water Healthcare and Medical-Related businesses. In the Water Healthcare segment, the company manufactures and sells electrolyzed hydrogen water ionizers and bottled water, providing products that support health.

The Water Healthcare segment is supported by multiple subsidiaries: Trim Electric Machinery manufactures electrolyzed hydrogen water ionizers, Trim Life Support handles installation and after-sales service, and Functional Water Cell Analysis Center conducts measurement and analysis of functional water and active hydrogen. Additionally, Guangzhou Duoning Health Technology and Duoning Biotech handle import and sales of electrolyzed hydrogen water ionizers, while PT. SUPER WAHANA TEHNO manufactures and sells bottled water. These companies work together to support the Water Healthcare business.

In the Medical-Related business, Stem Cell Research Institute operates a cell banking business, Strex manufactures and sells medical research equipment and medical devices, and Trim Medical Institute handles sales of electrolyzed water dialysis equipment. Han Kun International Holdings and Japan-China Medical Development also operate and manage medical businesses in China and provide specialized personnel dispatch services. Through these operations, Japan Trim pursues diversified business development in the medical field.

Japan Trim aims to become a global medical company with health and healthcare as its core pillars. The company is advancing management practices that prioritize ESG and SDGs, contributing to social sustainability and people's well-being. It operates water healthcare and medical-related businesses, with plans to strengthen its revenue base by expanding the medical-related business segment.

In the water healthcare business, Japan Trim anticipates growing demand for electrolyzed hydrogen water ionizers. Tailwinds include the gut health trend, growing understanding of hydrogen's benefits, and increased awareness of water quality pollution issues. The company aims to significantly expand its user base for ionizers and establish cartridge filter sales as a stable revenue stream.

In the medical-related business, Japan Trim is expanding electrolyzed water dialysis and regenerative medicine operations. Electrolyzed water dialysis is expected to improve quality of life for dialysis patients and contribute to hospital management. In regenerative medicine, the company offers umbilical cord blood and umbilical cord storage services, anticipating increased demand both domestically and internationally.

Japan Trim has established a medium-term management plan targeting consolidated net sales of 31 billion yen for the fiscal year ending March 2028. The company aims for sustainable growth through expanded ionizer sales and strengthened medical-related operations. It is also expanding its bottled water business in Indonesia, seeking to increase market share in the local market.

To achieve sustainable growth, the company is also focusing on strengthening sustainability initiatives, human resource development, and governance. It is promoting diversity in hiring and workplace reform to enhance corporate value. Through these efforts, Japan Trim is contributing to solving social challenges while strengthening its competitive advantage as a company.